Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilator Therapy in Familial Dysautonomia
NCT01987219Phase 3Completed
- Sponsor
- NYU Langone Health
- Start
- Mar 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of albuterol dry powder inhaler, ipratropium bromide in Familial dysautonomia (FD), sponsored by NYU Langone Health. Started Mar 2013; status: completed.
02
Drugs
albuterol dry powder inhaleripratropium bromide
03
Conditions
Familial dysautonomia (FD)
Beyond the preview
Go deeper on NCT01987219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987219.